March 25, 2024
A California federal judge concluded Monday that statements made by the chief executive officer of biotech company Pacific Biosciences to investors at an earnings call undermined the company's invalidity arguments in a patent suit it's facing.
December 04, 2023
A California federal judge on Monday disqualified all but one of Pacific Biosciences' in-house attorneys and legal support staff from working on a patent infringement case against the biotechnology company, adopting PacBio's proposed measures after the judge disqualified a former Perkins Coie LLP attorney last month.
November 06, 2023
A California federal judge on Monday disqualified a former Perkins Coie LLP attorney, now working in-house at Pacific Biosciences of California Inc., from helping out with a patent infringement case against the biotechnology company, though the judge declined to disqualify the entire in-house legal team as was requested.